CD36 (GPIV) Antibody, anti-human, PE, REAfinity™, 200 µL
文献支持

CD36 (GPIV) Antibody, anti-hum

an, PE, REAfinity™, 200 µL
收藏
  • 询价
  • Miltenyi Biotec已认证
  • 德国
  • 130-139-136
  • 2025年12月09日
  • MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
  • human cell line
  • human
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      CD36 (GPIV)

    • 亚型

      recombinant human IgG1

    • 形态

      Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.

    • 保存条件

      避光,4-8℃

    • 克隆性

      REA1491

    • 标记物

      PE

    • 适应物种

      human

    • 保质期

      24个月

    • 供应商

      Miltenyi Biotec

    • 宿主

      human cell line

    • 应用范围

      MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry

    • 浓度

      1:50

    • 抗体英文名

      CD36 (GPIV) Antibody, anti-human, REAfinity™

    • 抗体名

      CD36 (GPIV) Antibody, anti-human, REAfinity™

    • 规格

      200 µL

    Detection of CD36 (GPIV)+ cellsClone REA1491 recognizes the human CD36 antigen, an integral membrane protein, which is a member of the class B scavenger receptor family of cell surface proteins. CD36 is expressed on various epithelial and endothelial cells as well as erythrocytes, platelets, monocytes and macrophages, and some macrophage-derived dendritic cells. CD36 functions as a scavenger receptor for long chain fatty acids, oxidized LDL, collagen type I, IV, and V and thrombospondin, as well as for apoptotic cells. CD36 is an early marker of erythroid differentiation. |

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Silverstein, R. L. et al. (2009) CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2 (72): . | Chen, H. et al. Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease. EMBO Mol. Med. (doi: 10.1038/s44321-025-00224-4): . | Chew, V. et al. (2025) Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma. Clin Mol Hepatol: doi: 10.3350/cmh.2025.0334.
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    德国美天旎生物技术有限公司
    2025年12月09日询价
    询价
    普健生物(武汉)科技有限公司
    2025年07月12日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月09日询价
    ¥1106
    武汉尚恩生物技术有限公司
    2025年11月18日询价
    文献支持
    CD36 (GPIV) Antibody, anti-human, PE, REAfinity™, 200 µL
    询价